| Financial Year |
March 31 2023 |
| Monetary Funds |
1,586,810,529.23 |
| Held-for-trading Financial Assets |
132,283,150.68 |
| Notes Receivable |
9,335,765.93 |
| Accounts Receivable |
152,110,199.13 |
| Advances to Suppliers |
336,580,293.28 |
| Other Receivables |
37,504,615.38 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
496,384,233.50 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,164,823.47 |
| Total Current Assets |
2,756,173,610.60 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
152,877,322.86 |
| Investment Properties |
-- |
| Fixed Assetes |
11,620,400.66 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
12,779,993.52 |
| R&D expenses |
22,632,244.44 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
14,507,494.51 |
| Deferred Income Tax Assets |
3,866,743.20 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
498,781,196.37 |
| Total Assets |
3,254,954,806.97 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
71,229,559.57 |
| Accounts Payable |
640,877,312.87 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
82,102,164.58 |
| Taxes Payable |
7,667,572.92 |
| Interest Payable |
-- |
| Dividend Payable |
2,507,849.51 |
| Other payables |
85,019,940.67 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
44,622,437.99 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
1,002,838,128.63 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
162,550,038.97 |
| Total Liabilities |
1,165,388,167.60 |
| Paid-In Capital(Or Share Stock) |
190,151,515.00 |
| Capital Surplus |
751,222,270.35 |
| Surplus Reserve |
115,747,083.58 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,053,255,724.87 |
| Minority Stockholder's Interest |
-14,164,928.32 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,103,731,567.69 |
| Owner's Equity（Stockholder's Equity） |
2,089,566,639.37 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,254,954,806.97 |
